Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · Real-Time Price · USD
4.360
+0.040 (0.93%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Sight Sciences Revenue
In the year 2025, Sight Sciences had annual revenue of $77.36M, down -3.13%. Sight Sciences had revenue of $20.39M in the quarter ending December 31, 2025, with 6.87% growth.
Revenue (ttm)
$77.36M
Revenue Growth
-3.13%
P/S Ratio
3.07
Revenue / Employee
$415,930
Employees
186
Market Cap
237.20M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 348.67M |
| InfuSystem Holdings | 143.44M |
| RxSight | 134.48M |
| Electromed | 68.86M |
| CVRx, Inc. | 56.65M |
| 908 Devices | 56.20M |
| TriSalus Life Sciences | 45.15M |
| Senseonics Holdings | 35.26M |
SGHT News
- 6 days ago - Sight Sciences Announces the Release of its Sustainability Report - GlobeNewsWire
- 7 days ago - Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026 - GlobeNewsWire
- 15 days ago - Sight Sciences Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 27 days ago - Sight Sciences' Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - GlobeNewsWire
- 4 weeks ago - Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th - GlobeNewsWire
- 4 weeks ago - Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury's Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent - GlobeNewsWire
- 7 weeks ago - Sight Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 7 weeks ago - Sight Sciences Earnings Call Transcript: Q4 2025 - Transcripts